Novo Nordisk's shares fell 10% after the company said its oral semaglutide drug Rybelsus failed to meet the main goal in late-stage trials testing whether it
World

Novo Nordisk's shares fell 10% after the company said its oral semaglutide drug Rybelsus failed to meet the main goal in late-stage trials testing whether it could slow cognitive decline in early Alzheimer's patients. The setback dims hopes for expanding GLP-1 medicines into a major new market

2
3
4
5
6
7
8

Ultrahuman Brings Advanced Blood Vision Health Tests To Over 60 Cities In India: Know More

Posted By: Hari Ram Posted On: Nov 10, 2025Share Article
Ultrahuman Brings Advanced Blood Vision Health Tests To Over 60 Cities In India
Ultrahuman makes smart rings and has its own software tech to help users. (Photo: AI generated)

Ultrahuman Brings Advanced Blood Vision Health Tests To Over 60 Cities In India: Know More

Ultrahuman is building its health ecosystem in the Indian market after starting its focus in the other countries. The company makes smart rings with focus on health and now people in India will be getting doorstep service for its Blood Vision feature for which it has teamed up with Tata 1mg that will do the actual ground work.

The company is bringing this service to over 60 cities in the country that involves 2000+ PIN codes.

Ultrahuman has built its service with hardware and software in the mix which means it has full control over how the applications perform and deliver. Health-centric features in India are limited so a local operator enables them to reach a wider consumer base.

Ultrahuman Blood Vision Doorstep Tests: What It Offers

Ultrahuman is letting Tata 1mg offer a wide range of blood tests and around 15 of them have been curated with its own data points in place. The company has priced them starting from Rs 999 and the most expensive version with 60 biomarkers such as cardiovascular, hormonal and metabolic measures will cost you Rs 1,999.

Ultrahuman will use its tech expertise to provide the results straight on its app and assure users detailed information and highlight the parts that will need further checks. In addition to this, the company is bringing a free universal health interpreter, which it claims is a first in the market.

Swipe Left For Next Video

You can use the Vision Cloud feature to upload your older blood test results and get advice and further support on the app. The company plans to add other health subjects like cancer, CT scans and even MRI in the near future.

The smart ring and health segment in India is nascent and premium. Ultrahuman is looking to change that dynamic and is reportedly planning for more hardware products that align with the needs and data points of users in a particular region. Health and AI could be the go-to mix for most of the companies in the next few years and India is primed at the centre of their focus.

Comment on Post

Leave a comment

If you have a News Orbit 360 user account, your address will be used to display your profile picture.


Novo Nordisk's shares fell 10% after the company said its oral semaglutide drug Rybelsus failed to meet the main goal in late-stage trials testing whether it
World
Novo Nordisk says Alzheimer's drug trial fails to meet main goal

Novo Nordisk's shares fell 10% after the company said its oral semaglutide drug Rybelsus failed to meet the main goal in late-stage trials testing whether it could slow cognitive decline in early Alzheimer's patients. The setback dims hopes for expanding GLP-1 medicines into a major new market

3 months ago


Sing Up